Legend Biotech Corp
LEGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001801198
In the last 90 days, Legend Biotech Corp insiders filed 0 open-market purchases and 1 sale; 219 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Legend Biotech Corp changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 86 | 1 | 88 | +3 |
| Shares | 28.3M | 1.63M | 39.0M | +12.3M (+46.1%) |
| Value | $1.16B | $66.9M | $1.97B | +$875.7M (+79.9%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Legend Biotech Corp at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Johnson & Johnson | 1,629,173 | $82.4M | 7.23% |
| Wellington Management Group LLP | 592,635 | $30.0M | 0.01% |
| Adage Capital Partners GP, L.L.C. | 250,000 | $12.6M | 0.02% |
| Tri Locum Partners LP | 168,467 | $8.52M | 3.96% |
| International Biotechnology Trust PLC | 49,500 | $2.50M | 0.61% |
| Sante Capital Fund, LP | 36,617 | $1.85M | 1.71% |
| AtonRa Partners | 33,493 | $1.69M | 0.57% |
| Yong Rong (HK) Asset Management Ltd | 29,751 | $1.50M | 0.99% |
| Canada Pension Plan Investment Board | 28,600 | $1.45M | 0.00% |
| Ergoteles LLC | 16,008 | $809.0K | 0.03% |
| Natixis | 7,396 | $372.0K | 0.00% |
| ProShare Advisors LLC | 6,826 | $345.0K | 0.00% |
| Gsa Capital Partners LLP | 6,104 | $309.0K | 0.03% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 4,730 | $239.0K | 0.00% |
| Rockefeller Capital Management L.P. | 1,500 | $75.0K | 0.00% |
| US Bancorp | 332 | $17.0K | 0.00% |
| Bell Investment Advisors, Inc | 195 | $10.0K | 0.00% |
| Ironwood Financial, llc | 40 | $2.00K | 0.00% |
| O'Shaughnessy Asset Management, LLC | 8 | $0 | 0.00% |
Sold out (16)
Institutions that held Legend Biotech Corp at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Consonance Capital Management LP | 1,647,497 | $67.6M |
| Ra Capital Management, L.P. | 977,503 | $40.1M |
| Novo Holdings A/S | 279,676 | $11.5M |
| Two Sigma Investments, LP | 141,689 | $5.82M |
| Marshall Wace, LLP | 141,375 | $5.80M |
| Indus Capital Partners, LLC | 94,678 | $3.89M |
| Renaissance Technologies LLC | 60,800 | $2.50M |
| Susquehanna International Group, LLP | 56,309 | $2.31M |
| Blueshift Asset Management, LLC | 10,871 | $446.0K |
| Two Sigma Advisers, LP | 8,400 | $345.0K |
| Weiss Multi-Strategy Advisers LLC | 8,106 | $333.0K |
| Virtu Financial LLC | 7,375 | $303.0K |
| Aigen Investment Management, LP | 5,628 | $231.0K |
| Quantbot Technologies LP | 2,600 | $106.0K |
| Pinz Capital Management, LP | 700 | $29.0K |
| Royal Bank of Canada | 41 | $2.00K |
Not filed for Q3 2021 yet (1)
Institutions that held Legend Biotech Corp at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66.9M |